The effect of an antimicrobial restriction program on Pseudomonas aeruginosa resistance to β-lactams in a large teaching hospital

被引:29
作者
Regal, RE
DePestel, DD
VandenBussche, HL
机构
[1] Univ Michigan, Hlth Syst, Dept Pharm Serv, UH B2D301, Ann Arbor, MI 48109 USA
[2] Coll Pharm, Ann Arbor, MI 48109 USA
来源
PHARMACOTHERAPY | 2003年 / 23卷 / 05期
关键词
D O I
10.1592/phco.23.5.618.32197
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objectives. To compare the use of beta-lactams and subsequent Pseudomonas aeruginosa sensitivity patterns before and after implementation of a clinical pharmacist-facilitated antimicrobial restriction program in August 1997. Design. Retrospective consecutive data collection. Setting. Large university-affiliated medical center. Intervention. The study results are the accumulation of the daily intervention activities of the antimicrobial restriction program. Data on antimicrobial grams purchased/1000 patient-days and susceptibility patterns were collected and analyzed retrospectively. Measures and Main Results. Annual grams of ceftazidime, piperacillin, piperacillin-tazobactam, and other antipseudomonal beta-lactams purchased/1000 patient-days were compared during the 2 full calendar years before the antimicrobial restriction program (1995-1996) with the 4 full calendar years after the program was implemented (1998-2001). Pseudomonas aeruginosa resistance trends for the antipseudomonal beta-lactams, ciprofloxacin, and tobramycin also were compared for the 2 years before the program (1995-1996) with the last 2 years of the program (2000-2001). A 44% reduction in ceftazidime use was documented; ostensibly, minimal changes occurred in the overall use of piperacillin and piperacillin-tazobactam. During the same time period, ceftazidime resistance fell from 24% to 11.8% (p<0.001), whereas piperacillin resistance fell from 32.5% to 18.5% (p<0.001). Imipenem resistance declined from 20.5% to 12.3% (p<0.001) with an 18% reduction in use. Aztreonam resistance declined from 29.5% to 16.5% (p<0.001) despite a 57% increase in use. No changes in resistance to either ciprofloxacin or tobramycin were found. Conclusion. Through an antimicrobial restriction program, a dramatic reduction in ceftazidime use was achieved with judicious use of other antipseudomonal antimicrobials, which resulted in reduced resistance of P aeruginosa to other beta-lactams.
引用
收藏
页码:618 / 624
页数:7
相关论文
共 25 条
[11]   NOSOCOMIAL OUTBREAK OF KLEBSIELLA INFECTION RESISTANT TO LATE-GENERATION CEPHALOSPORINS [J].
MEYER, KS ;
URBAN, C ;
EAGAN, JA ;
BERGER, BJ ;
RAHAL, JJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (05) :353-358
[12]  
*NAT COMM CLIN LAB, 2000, PERF STAND ANT DISK, V20
[13]  
*NAT COMM CLIN LAB, 2002, PERF STAND ANT SUSC, V22
[14]  
National Committee for Clinical Laboratory Standards, 2000, METH DIL ANT SUSC TE, V20
[15]   Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae [J].
Patterson, JE ;
Hardin, TC ;
Kelly, CA ;
Garcia, RC ;
Jorgensen, JH .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (07) :455-458
[16]  
Pollack M, 2000, PRINCIPLES PRACTICE, V5th ed.
[17]  
POSTELNICK MJ, 1998, J CLIN OUTCOMES MANA, V5, P21
[18]   Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci [J].
Quale, J ;
Landman, D ;
Saurina, G ;
Atwood, E ;
DiTore, V ;
Patel, K .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) :1020-1025
[19]   Glass restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella [J].
Rahal, JJ ;
Urban, C ;
Horn, D ;
Freeman, K ;
Segal-Maurer, S ;
Maurer, J ;
Mariano, N ;
Marks, S ;
Burns, JM ;
Dominick, D ;
Lim, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (14) :1233-1237
[20]   OUTBREAK OF CEFTAZIDIME RESISTANCE CAUSED BY EXTENDED-SPECTRUM BETA-LACTAMASES AT A MASSACHUSETTS CHRONIC-CARE FACILITY [J].
RICE, LB ;
WILLEY, SH ;
PAPANICOLAOU, GA ;
MEDEIROS, AA ;
ELIOPOULOS, GM ;
MOELLERING, RC ;
JACOBY, GA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (11) :2193-2199